Intravaginal ring as human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) prevention

Authors

DOI:

https://doi.org/10.18573/bsdj.221

Keywords:

Acquired Immunodeficiency Syndrome, Anti-Retroviral Agents, Human Immunodeficiency Virus, Pre-Exposure Prophylaxis, Vertical Transmission

Abstract

Summary: HIV/AIDS is one of the primary concerns of the Sustainable Development Goals. It has a high prevalence and causes significant effects for the sufferers. Several prevention methods against HIV infection have been developed, including the intravaginal rings loaded with antiretroviral drugs. We aimed to inform about the potential use of an intravaginal ring as pre-exposure prophylaxis

Relevance: Recently available methods of HIV/AIDS prevention have many pitfalls, especially in compliance, resulting in inconsistent efficacy. New methods of prevention need to be addressed, and intravaginal rings can be used following abundant evidence stating their efficacy, compliance, and patient preference. 

Take-home messages: Intravaginal rings have the potential to be used as a pre-exposure prophylaxis against HIV infection.. 

Author Biography

  • Tungki Pratama Umar, Sriwijaya University
    Mr. Tungki Pratama Umar is a medical doctor graduate from Sriwijaya University. His research interest is mainly in biomedicine, pharmacology, primary care, and public health. He got an award as best scientific paper writer in Outstanding Student Selection of Sriwijaya University, then 1st and 3rd winner of Research Paper Competition in SPORA by 2018. He is also listed as the reviewer and editorial board in several international peer-reviewed journals.

Downloads

Published

2022-12-01

Issue

Section

Life – Education